Preclinical biotech developing non-invasive topical therapy for eye diseases.
| Date | Round | Amount |
|---|---|---|
| Jun 2024 | Seed BIOPHTA closed €6.5M in seed funding led by UI Investissement, Elaia and GO Capital to advance its ophthalmology technology toward clinical development. | $7M |